In the news: Lisa Harder talks about clinical trials
Patient partner and PHA Canada Knowledge Philanthropist Lisa Harder was in the news twice recently, talking about her experience with the sotatercept clinical trial. University of Alberta Folio: New program aims to fast-track clinical trials across the province (September 24) CBC Alberta at Noon: Clinical trials (August 17) Thank you for sharing your experiences, Lisa, and congratulations on the media coverage! Find out more about clinical trials in Canada
It's in the Genes: How Genetics Is Reshaping Our Understanding of PAH
Many health awareness campaigns around the world attribute the progression of diseases to environmental and lifestyle factors; however, genetics is often forgotten. For many diseases, a patient’s genetics is an important biological driver. Genetics is a branch of biology focusing on genes, heredity and genetic variation. All of these combine to explain how traits and diseases can be passed from parents to their children through DNA. In a consensus report summarizing the 7th
Pulmonary Hypertension Global Patient Survey
In 2023, the Pulmonary Vascular Research Institute (PVRI) launched a Pulmonary Hypertension Global Patient Survey. The first global survey of those living with pulmonary hypertension (PH) and their caregivers, it aimed to help clinicians better understand the impacts of pulmonary hypertension on patients. Pulmonary hypertension affects people of all ages, genders and demographics, so a truly global response is required. As the only global pulmonary vascular disease charity, t
.jpg)
